Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial

BACKGROUND. The objective of this study was to evaluate the prognostic value of the cumulative cisplatin dose (CCD) for long-term survival outcomes after concurrent chemoradiotherapy (CCRT) in locoregionally advanced nasopharyngeal carcinoma (NPC). METHODS. Patients were included in an open-label ph...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Autores principales: Peng, Hao, Chen, Lei, Zhang, Yuan, Li, Wen-Fei, Mao, Yan-Ping, Zhang, Fan, Guo, Rui, Liu, Li-Zhi, Lin, Ai-Hua, Sun, Ying, Ma, Jun
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2016
Materias:
Head and Neck Cancer
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5189617/
https://ncbi.nlm.nih.gov/pubmed/27496040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0105
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares